These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6377102)

  • 1. Activation of plasma prorenin by plasminogen activators in vitro and increase in plasma renin after stimulation of fibrinolytic activity in vivo.
    Derkx FH; Brommer EJ; Boomsma F; Schalekamp MA
    Neth J Med; 1984; 27(4):124-8. PubMed ID: 6377102
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of plasma prorenin by plasminogen activators in vitro and increase in plasma renin after stimulation of fibrinolytic activity in vivo.
    Derkx FH; Brommer EJ; Boomsma F; Schalekamp MA
    Clin Exp Hypertens A; 1982; 4(11-12):2247-58. PubMed ID: 6756694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental studies of the liberation of plasminogen activator by DDAVP].
    Jablonowski C; Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemia.
    Brommer EJ; Gevers Leuven JA; Barrett-Bergshoeff MM; Schouten JA
    J Lab Clin Med; 1982 Jul; 100(1):105-14. PubMed ID: 6806418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolysis, renin activity, and prorenin in normal women: effects of exercise and oral contraceptive medication.
    Hedlin AM; Loh AY; Osmond DH
    J Clin Endocrinol Metab; 1979 Nov; 49(5):663-71. PubMed ID: 158599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increase in the fibrinolytic activity in patients with hyperlipoproteinemias type IV treated with bezafibrate].
    Obispo TM; García Fradé LJ; García Avelló A; César J; Sastre A; Navarro JL
    Rev Clin Esp; 1988 Feb; 182(3):151-4. PubMed ID: 3368592
    [No Abstract]   [Full Text] [Related]  

  • 9. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
    Leckie BJ; Morton JJ
    J Hum Hypertens; 1995 Jun; 9(6):493-6. PubMed ID: 7473533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular interactions during fibrinolysis. Search for new plasminogen activators].
    Maksimenko AV
    Mol Biol (Mosk); 1995; 29(1):38-60. PubMed ID: 7723763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders.
    Brommer EJ; Barrett-Bergshoeff MM; Allen RA; Schicht I; Bertina RM; Schalekamp MA
    Thromb Haemost; 1982 Oct; 48(2):156-61. PubMed ID: 6817444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma.
    Brommer EJ; Verheijen JH; Chang GT; Rijken DC
    Thromb Haemost; 1984 Oct; 52(2):154-6. PubMed ID: 6441302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma "prorenin"-renin in Bartter's syndrome, cystic fibrosis, and chloride deficiency, and the effect of prostaglandin synthetase inhibition.
    Chan LL; Osmond DH; Balfe JW; Halperin ML
    J Lab Clin Med; 1981 Jun; 97(6):785-90. PubMed ID: 6785370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy in fibrinolytic response to desmopressin as compared to venous occlusion--a preliminary report.
    Nilsen DW; Andersen P; Hjermann I; Godal HC
    Thromb Haemost; 1985 Feb; 53(1):160. PubMed ID: 3992517
    [No Abstract]   [Full Text] [Related]  

  • 17. Inactive renin in human plasma. Is it prorenin?
    Hsueh WA
    Miner Electrolyte Metab; 1982 Apr; 7(4):169-78. PubMed ID: 6763144
    [No Abstract]   [Full Text] [Related]  

  • 18. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
    Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
    Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
    Sundsmo JS; Wood LM
    J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.